floatz AI logo

floatz AI

Paid

AI-Driven Scientific Due Diligence for Life-Science Investors

HealthcareContact
Inputs: text
Type
Saas
Company
floatz

About floatz AI

floatz AI for Drug Discovery helps surface high-potential drug targets grounded in human genetics, expression patterns, and biological pathways, built for translational success. It integrates human genetics, tissue expression, and pathway analysis to map billions of concepts and identify targets with real translational potential, delivering 3 clinically-relevant targets in 14 days.

How to Use

Users define their strategic focus (therapeutic area, indication, constraints). floatz then analyzes the opportunity space by combining literature, disease biology, omics data, pathway networks, and competitive intelligence. Finally, floatz curates and shortlists three high-potential targets, providing scientific rationale, referenced data, and expert review in a decision-ready PDF brief within 14 days.

Key Features

  • AI-driven drug target identification
  • Integration of human genetics, tissue expression, and pathway analysis
  • Delivery of 3 clinically-relevant targets in 14 days
  • Multi-layered analysis (literature, omics, disease biology, competitive intelligence)
  • Expert-reviewed target selection

Use Cases

  • Identifying novel drug targets for specific disease areas
  • Expanding existing drug programs or exploring new therapeutic spaces
  • Informing strategic decision-making or licensing evaluation for drug development

Key Features

AI-driven drug target identification
Integration of human genetics, tissue expression, and pathway analysis
Delivery of 3 clinically-relevant targets in 14 days
Multi-layered analysis (literature, omics, disease biology, competitive intelligence)
Expert-reviewed target selection

Pros & Cons

Pros
  • Fast turnaround: 3 high-quality targets delivered in 14 days
  • Multi-layered analysis combining genetics, expression, pathways, and competitive intelligence
  • Expert-reviewed output with scientific rationale and references
  • Specifically designed for translational success and clinical relevance
Cons
  • Pricing requires contacting sales (no visible pricing tiers)
  • Limited to therapeutic areas where sufficient omics and literature data are available

Best For

Identifying novel drug targets for specific disease areasExpanding existing drug programs or exploring new therapeutic spacesInforming strategic decision-making or licensing evaluation for drug development

Alternatives to floatz AI